Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
15.57%
↑ 116% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-94.66%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 15.57% | +583.6% |
| 2024 | 2.28% | +101.8% |
| 2023 | -129.03% | +44.8% |
| 2022 | -233.65% | +17.5% |
| 2021 | -283.18% | -435.5% |
| 2020 | -52.88% | +11.6% |
| 2019 | -59.80% | +46.0% |
| 2018 | -110.76% | -24196.8% |
| 2013 | -0.46% | - |